PrecisionMed Inc. Announces Longitudinal Multiple Sclerosis and Clinically Isolated Syndrome Spinal Fluid Biological Sample Registry

SAN DIEGO--(BUSINESS WIRE)--PrecisionMed Inc. today announced at the Society for Neuroscience annual meeting in San Diego, enrollment of the first subject into the PrecisionMed Multiple Sclerosis (MS) Registry. The PrecisionMed MS Registry is a biological sample bank of DNA and serial RNA, CSF, serum and plasma associated with serial clinical testing utilizing PrecisionMed's clinical data procurement and storage capabilities.